Oncogenes, estradiol biotransformation, and mammary carcinogenesis

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 277-287

  Telang, Nitin T ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA;

ANIMAL CELL; BIOTRANSFORMATION; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HORMONE METABOLISM; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; ONCOGENE RAS; PROTO ONCOGENE;

ANIMALIA;

EID: 0029920102     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16242.x     Document Type: Conference Paper

References (43)

1. NANDI, S. & C. M. MCGRATH. 1973. Mammary neoplasia in mice. Adv. Cancer Res. 17: 354-414.
2. MEDINA, D. 1976. Preneoplastic lesions in murine mammary cancer. Cancer Res. 36: 3584-3595.
3. RUSSO, J. & I. H. RUSSO. 1987. Biological and molecular basis of mammary carcinogenesis. Lab. Invest. 57: 112-137.
4. SQUARTINI, F., M. BISTOCHHI, R. SARANELLI & F. BASOLO. 1986. Early pathogenic changes in experimental and human breast cancer. Ann. N.Y. Acad. Sci. 464: 231-261.
5. TELANG, N. T. & M. P. OSBORNE. 1992. Ras oncogene: a novel molecular biomarker for breast cancer susceptibility and prevention. In Current Perspectives on Molecular and Cellular Oncology. D. A. Spandidos, Ed.: 95-118. Jai Press. Greenwich, Connecticut.
6. TELANG, N. T., H. L. BRADLOW & M. P. OSBORNE. 1992. Molecular and endocrine biomarkers in noninvolved breast: relevance to cancer chemoprevention. J. Cell. Biochem. 16G: 161-169.
7. BORG, A. 1992. Gene alterations in human breast cancer. In Current Perspectives on Molecular and Cellular Oncology. D. A. Spandidos, Ed.: 22-80. Jai Press. Greenwich, Connecticut.
8. SUKUMAR, S. 1990. An experimental analysis of ras oncogenes in multistep carcinogenesis. Cancer Cells 2: 199-204.
9. KUMAR, R., S. SUKUMAR & M. BARBACID. 1990. Activation of ras oncogenes preceding the onset of neoplasia. Science 248: 1101-1104.
10. SINN, E., W. MULLER, P. PATTENGALE et al. 1987. Coexpression of MMTV/vHa-Ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49: 465-475.
11. SCHOENBERGER, C. A., A. C. ANDRESS, B. GRONER et al. 1988. Targeted c-myc gene expression in mammary glands of transgenic mice induced mammary tumors with constitutive milk protein gene transcription. EMBO J. 6: 169-175.
12. TREMBLAY, P. J., F. POTHIER, T. HOANG et al. 1989. Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects on various tissues. Mol. Cell. Biol. 9: 854-859.
13. MULLER, W., F. S. LEE, C. DICKSON et al. 1990. The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 9: 907-913.
14. MULLER, W., E. SINN, P. K. PATTENGALE et al. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105-115.
15. BOUCHARD, L., L. LAMARRE, P. J. TREMBLAY et al. 1989. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57: 931-936.
16. ADAMS, J. B. 1991. Enzymatic regulation of estradiol-17β concentrations in human breast cancer cells. Breast Cancer Res. Treat. 20: 145-154.
17. MARTUCCI, C. P. & J. FISHMAN. 1993. P450 enzymes of estrogen metabolism. Pharmacol. Ther. 57: 237-257.
18. SCHNEIDER, J., D. KINNE, A. FRACCHIA et al. 1982. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. U.S.A. 79: 3047-3051.
19. OSBORNE, M. P., R. A. KARMALI, H. L. BRADLOW et al. 1966. Omega-3 fatty acids: modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Invest. 6: 629-631.
20. BRADLOW, H. L., R. J. HERSCHCOPF, C. P. MARTUCCI et al. 1985. Estradiol 16α-hydroxylation correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. U.S.A. 82: 6295-6299.
21. SCHNEIDER, R., M. M. HUH, H. L. BRADLOW et al. 1984. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem. 259: 4840-4845.
22. LOTTERING, M. L., M. HAAG & J. C. SEEGERS. 1992. Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res. 52: 5926-5932.
23. TELANG, N. T., M. R. BANERJEE, A. P. IYER et al. 1979. Neoplastic transformation of epithelial cells in whole mammary gland in vitro. Proc. Natl. Acad. Sci. U.S.A. 76: 5886-5890.
24. TELANG, N. T., H. KURIHARA, G. Y. WONG et al. 1991. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention. Anticancer Res. 11: 1021-1028.
25. TELANG, N. T., M. P. OSBORNE, L. SWETERLITSCH et al. 1990. Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. Cell Regul. 1: 863-872.
26. TELANG, N. T., R. NARAYANAN, H. L. BRADLOW et al. 1991. Coordinated expression of intermediate biomarkers for tumorigenic transformation in Ras-transfected mouse mammary epithelial cells. Breast Cancer Res. Treat. 18: 155-163.
27. TELANG, N. T. & N. H. SARKAR. 1983. Long-term survival of adult mouse mammary glands in culture and their response to a retinoid. Cancer Res. 43: 4891-4900.
28. TELANG, N. T., A. BASU, H. KURIHARA et al. 1988. Modulation in the expression of murine mammary tumor virus, of ras protooncogenes, and of alveolar hyperplasia by fatty acids in mouse mammary explant cultures. Anticancer Res. 8: 971-976.
29. TELANG, N. T., A. SUTO, G. Y. WONG et al. 1992. Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J. Natl. Cancer Inst. 84: 634-638.
30. GARG, A., A. SUTO, M. P. OSBORNE et al. 1993. Expression of biomarkers for transformation in 7,12-dimethyibenz(a)anthracene-treated mammary epithelial cells. Int. J. Oncol. 3: 185-189.
31. SUTO, A., H. L. BRADLOW, G. Y. C. WONG et al. 1993. Experimental downregulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res. Treat. 27: 193-202.
32. VAN DER VALK, M. A. 1981. Survival, tumor incidence, and gross pathology in 33 mouse strains. In Mammary Tumors in the Mouse. J. Hilgers & M. Sluyser, Eds.: 45-115. Elsevier/North-Holland. Amsterdam/New York.
33. CASTAGNETTA, L., O. M. GRANATA, M. LOCASTO et al. 1991. Simple approach to measure metabolic pathways of steroids in living cells. J. Chromatogr. 572: 25-39.
34. FISHMAN, J., H. L. BRADLOW, J. SCHNEIDER et al. 1980. Radiometric analysis of oxidation in man: sex differences in estradiol metabolism. Proc. Natl. Acad. Sci. U.S.A. 77: 4957-4960.
35. MAUVAIS-JARVIS, P., F. KUTTEN & A. COMPEL. 1986. Estrogen/progesterone interaction in normal and pathologic breast cells. Ann. N.Y. Acad. Sci. 464: 152-167.
36. DUBIK, D. & R. P. C. SHIU. 1992. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594.
37. WEISZ, A. & F. BRESCIANI. 1993. Estrogen regulation of protooncogenes coding for nuclear proteins. Crit. Rev. Oncog. 4: 361-388.
38. WELSCH, C. W. 1985. Host factors affecting the growth of carcinogen-induced rat mammary carcinoma: a review and tribute to Charles Brenton Huggins. Cancer Res. 45: 3415-3443.
39. GABOR, H. & S. ABRAHAM. 1986. Effect of dietary menhaden oil on tumor cell loss and the accumulation of mass of a transplantable mammary adenocarcinoma in BALB/c mice. J. Natl. Cancer Inst. 76: 637-645.
40. SPORN, M. B. & D. L. NEWTON. 1979. Chemoprevention of cancer with retinoids. Fed. Proc. 38: 2528-2531.
41. BRADLOW, H. L., J. J. MICHNOVICZ, N. T. TELANG et al. 1991. Effect of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12: 1571-1574.
42. JORDAN, V. C., M. LABABIDI & S. LANGHAN-FAHEY. 1991. Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J. Natl. Cancer Inst. 83: 492-496.
43. TELANG, N. T., H. L. BRADLOW & M. P. OSBORNE. 1994. Effect of tamoxifen on mammary preneoplasia: relevance to cancer chemoprevention. Cancer Detect. Prev. 18: 313-321.